These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10458149)

  • 21. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 22. US court case to define EST patentability.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract]   [Full Text] [Related]  

  • 23. Roche's Taq patent 'obtained by deceit', rules US court.
    Dalton R
    Nature; 1999 Dec; 402(6763):709. PubMed ID: 10617182
    [No Abstract]   [Full Text] [Related]  

  • 24. Proposal for US patent office could help cut waiting time.
    Smaglik P
    Nature; 2000 Jul; 406(6794):334. PubMed ID: 10935603
    [No Abstract]   [Full Text] [Related]  

  • 25. US court bolsters biotech patent protection.
    Harrison C
    Nat Biotechnol; 2011 Aug; 29(8):672-3. PubMed ID: 21822224
    [No Abstract]   [Full Text] [Related]  

  • 26. New rules for gene patents.
    Grisham J
    Nat Biotechnol; 2000 Sep; 18(9):921. PubMed ID: 10973202
    [No Abstract]   [Full Text] [Related]  

  • 27. Patents. U.S. Supreme Court delves into what is and isn't patentable.
    Marshall E
    Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotechnology inventions in the health care environment: what to patent and how to avoid defeat.
    Murashige KR
    Benders Health Care Law Mon; 1995 Dec; ():3-10. PubMed ID: 10158648
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 31. Metal bashing.
    Nat Biotechnol; 2001 May; 19(5):391. PubMed ID: 11328978
    [No Abstract]   [Full Text] [Related]  

  • 32. What Markman should mean to you.
    Rzucidlo EC; Auth DR
    Nat Biotechnol; 1996 Jul; 14(7):888-90. PubMed ID: 9631017
    [No Abstract]   [Full Text] [Related]  

  • 33. Patent reform prompts intellectual tug-of-war.
    Nature; 2005 Oct; 437(7063):1230-1. PubMed ID: 16251923
    [No Abstract]   [Full Text] [Related]  

  • 34. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
    Marshall E
    Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

  • 36. Process patent bill on track.
    Gershon D
    Nature; 1993 Jul; 364(6435):274. PubMed ID: 8332176
    [No Abstract]   [Full Text] [Related]  

  • 37. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 38. US Patent Office strategic plan may penalize biotechs.
    Robertson D
    Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807
    [No Abstract]   [Full Text] [Related]  

  • 39. Court leaves patent issue unclear.
    Marshall E
    Science; 1991 Oct; 254(5030):368. PubMed ID: 1925589
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.